MD Anderson Cancer Center and Accelerator Life Science Partners announced the launch of Magnolia Neurosciences Corp., a company developing a new class of neuroprotective medicines, with $31 million in Series A funding. The company will develop novel therapeutics based on discoveries made by researchers in MD Anderson's Therapeutics Discovery division, including the Institute for Applied Cancer Science and the Neurodegeneration Consortium.
Members of the UCLA urology department received $9.3 million of funding from the state of California to help combat the financial burden of cancer treatment for men diagnosed with prostate cancer.
Ana María López joined the Sidney Kimmel Cancer Center–Jefferson Health as the vice chair of medical oncology and chief of cancer services at the Sidney Kimmel Cancer Center–Washington Township.
Fox Chase Cancer Center has hired Julio Noriega as an assistant professor in the Division of Pulmonary, Critical Care, and Sleep Medicine.
Cancer Treatment Centers of America Global Inc. announced enterprise-wide promotions:
Jim Cox, professor emeritus in radiation oncology at the University of Texas MD Anderson Cancer Center, passed away on Aug. 14. He was 80.
The US Senate Aug. 23 passed a spending bill that will increase the NIH budget by $2 billion to $39.1 billion—a 5.4 percent boost over the current level.
Intricate deception went into luring NIH Director Francis Collins onto Sacha Baron Cohen's television show.
Billy Wayne Ruddick Jr., Ph.D., is a character eerily reminiscent of someone we know, a distant relative who picks political fights on Facebook and Twitter.
FDA approved Magtrace and Sentimag Magnetic Localization System (Sentimag System), a magnetic device system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy. It uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.
